The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage
Open accessAbstract
CD26 is a leukocyte activation marker that possesses dipeptidyl peptidase IV activity but whose natural substrates and immunological functions have not been clearly defined. Several chemo-kines, including RANTES (regulated on activation, normal T cell expressed and secreted), have now been shown to be substrates for recombinant soluble human CD26. The truncated RANTES(3–68) lacked the ability of native RANTES(1–68) to increase the cytosolic calcium concentration in human monocytes, but still induced this response in macrophages activated with macrophage colony-stimulating factor. Analysis of chemokine receptor messenger RNAs and patterns of desensitization of chemokine responses showed that the differential activity of the truncated molecule results from an altered receptor specificity. RANTES(3–68) showed a reduced activity, relative to that of RANTES(1–68), with cells expressing the recombinant CCR1 chemokine receptor, but retained the ability to stimulate CCR5 receptors and to inhibit the cytopathic effects of HIV-1. Our results indicate that CD26-mediated processing together with cell activation–induced changes in receptor expression provides an integrated mechanism for differential cell recruitment and for the regulation of target cell specificity of RANTES, and possibly other chemokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., et al. (1996) · Nature · doi:10.1038/382833a0 · Cited by 1,652
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,195
Molecular cloning and structure of a pre-B-cell growth-stimulating factor.
Nagasawa, T., Kikutani, H., & Kishimoto, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2305 · Cited by 803
Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene
Samson, M., Labbe, O., Mollereau, C., Vassart, G., & Parmentier, M. (1996) · Biochemistry · doi:10.1021/bi952950g · Cited by 686
A human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Van Damme, J., Proost, P., Lenaerts, J. P., & Opdenakker, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.59 · Cited by 371
Berson, J. F., Long, D., Doranz, B. J., Rucker, J., Jirik, F. R., & Doms, R. W. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6288-6295.1996 · Cited by 346
CD26: a surface protease involved in T-cell activation
Fleischer, B. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90316-6 · Cited by 325
Chemokine receptors: Structure, function and role in microbial pathogenesis
Murphy, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00009-3 · Cited by 320
HIV blocked by chemokine antagonist
Arenzana-Seisdedos, F., Virelizier, J.-L., Rousset, D., Clark-Lewis, I., Loetscher, P., Moser, B., & Baggiolini, M. (1996) · Nature · doi:10.1038/383400a0 · Cited by 281
Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N. C., Luini, W., Polentarutti, N., Sozzani, S., & Mantovani, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.969 · Cited by 280
Proline specific endo- and exopeptidases
Walter, R., Simmons, W., & Yoshimoto, T. (1980) · Molecular and Cellular Biochemistry · doi:10.1007/bf00227927 · Cited by 256
Cheng-Mayer, C., Quiroga, M., Tung, J. W., Dina, D., & Levy, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4390-4398.1990 · Cited by 251
Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
Fox, D. A., Hussey, R. E., Fitzgerald, K. A., Acuto, O., Poole, C., Palley, L., Daley, J. F., Schlossmann, S. F., & Reinherz, E. L. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.3.1250 · Cited by 235
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.2090 · Cited by 202
Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J., & Gerard, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6854 · Cited by 181
Cloning and functional expression of the T cell activation antigen CD26
Tanaka, T., Camerini, D., Seed, B., Torimoto, Y., Dang, N. H., Kameoka, J., Dahlberg, H. N., Schlossman, S. F., & Morimoto, C. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.2.481 · Cited by 178
The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.
Hegen, M., Niedobitek, G., Klein, C. E., Stein, H., & Fleischer, B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2908 · Cited by 167
RANTES and MCP-3 Antagonists Bind Multiple Chemokine Receptors
Gong, J.-H., Uguccioni, M., Dewald, B., Baggiolini, M., & Clark‐Lewis, I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10521 · Cited by 146
Rahfeld, J., Schierborn, M., Hartrodt, B., Neubert, K., & Heins, J. (1991) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(91)90284-7 · Cited by 139
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.
Tanaka, T., Duke‐Cohan, J. S., Kameoka, J., Yaron, A., Lee, I., Schlossman, S. F., & Morimoto, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3082 · Cited by 124
Weber, M., Uguccioni, M., Baggiolini, M., Clark‐Lewis, I., & Dahinden, C. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.2.681 · Cited by 116
Davis, S. J., Ward, H. A., Puklavec, M. J., Willis, A. C., Williams, A., & Barclay, A. N. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86961-7 · Cited by 115
Duke‐Cohan, J. S., Morimoto, C., Rocker, J. A., & Schlossman, S. F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1714 · Cited by 87
McCaughan, G. W., Wickson, J. E., Creswick, P. F., & Gorrell, M. D. (1990) · Hepatology · doi:10.1002/hep.1840110403 · Cited by 74
Self-citationNoso, N., Sticherling, M., Bartels, J., Mallet, A. I., Christophers, E., & Schröder, J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1946 · Cited by 61
Oravecz, T., Roderiquez, G., Koffi, J.-N. N., Wang, J., Ditto, M., Bou‐Habib, D. C., Lusso, P., & Norcross, M. A. (1995) · Nature Medicine · doi:10.1038/nm0995-919 · Cited by 51
Self-citation
Cited by
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
RANTES: a versatile and controversial chemokine
Appay, V., & Rowland-Jones, S. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01812-3 · Cited by 650
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
Mulvihill, E. E., & Drucker, D. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1035 · Cited by 609
Metadata
- Authors
- Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., & Norcross, M. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-12-01
- Volume
- 186
- Issue
- 11
- Pages
- 1865-1872
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2169951035
- Cited by
- 332
- References
- 34
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.